Grant: Project Grant
McGill University
$875,925.00
A new model to study the role of intestinal inflammation as a driver of Parkinson's Disease development
FY 2018-19
Summary
In recent years, more and more evidence has accumulated in support of the idea that the gut and the bacteria within it can influence susceptibility to a wide range of diseases, including ones not classically thought of as intestinal diseases. For example, a growing body of evidence now supports the idea that important triggers of Parkinson's disease, a progressive nervous system disorder that affects movement, occur in the gut. We have recently shown, in a mouse model with a mutation in a Parkinson's Disease-associated gene, that Parkinson's Disease symptoms develop only after infection with bacteria that cause intestinal inflammation and short-term diarrheal disease. This is consistent with new lines of evidence from other studies which have recently uncovered an association between intestinal inflammation and Parkinson's Disease. For example, people suffering from inflammatory bowel disease are much more likely to develop Parkinson's Disease. Our discovery now provides us with a unique system to investigate exactly how events in the intestine can influence the development of Parkinson's Disease. Using this model we can now study in more detail the specifics of how intestinal bacteria are involved in this process, which of the intestinal responses to the infection are important, and how the signals in the gut get relayed to the brain. We anticipate that our studies may lead to the new ways to detect or prevent Parkinson's Disease early on in its development and before any of the motor symptoms occur.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
389688
Name
Gruenheid Samantha L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Hematology, Digestive Disease & Kidney
Projecttitle
A new model to study the role of intestinal inflammation as a driver of Parkinson's Disease development
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$875,925
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Gut-Brain Axis; Inflammatory Bowel Disease; Intestinal Health And Disease; Intestinal Infection; Intestinal Inflammation; Mouse Models Of Disease
Abstract
In recent years, more and more evidence has accumulated in support of the idea that the gut and the bacteria within it can influence susceptibility to a wide range of diseases, including ones not classically thought of as intestinal diseases. For example, a growing body of evidence now supports the idea that important triggers of Parkinson's disease, a progressive nervous system disorder that affects movement, occur in the gut. We have recently shown, in a mouse model with a mutation in a Parkinson's Disease-associated gene, that Parkinson's Disease symptoms develop only after infection with bacteria that cause intestinal inflammation and short-term diarrheal disease. This is consistent with new lines of evidence from other studies which have recently uncovered an association between intestinal inflammation and Parkinson's Disease. For example, people suffering from inflammatory bowel disease are much more likely to develop Parkinson's Disease. Our discovery now provides us with a unique system to investigate exactly how events in the intestine can influence the development of Parkinson's Disease. Using this model we can now study in more detail the specifics of how intestinal bacteria are involved in this process, which of the intestinal responses to the infection are important, and how the signals in the gut get relayed to the brain. We anticipate that our studies may lead to the new ways to detect or prevent Parkinson's Disease early on in its development and before any of the motor symptoms occur.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gruenheid, Samantha L
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $875,925~ $0~